Developmental Disorders of the Lymphatics

An information blog for disorders of the lymphatics. For all articles, please click on "Archives" - Due to spammers, I will no longer allow comments, sorry.

Wednesday, October 28, 2009

Understanding the Lymph System

Understanding the Lymph System

I thought it would be helpful for readers to understand the lymph system, the anatomy, what it does, and how it helps with immunity.

Listed below are information pages that should be quite helpful and each page has many additional links for more a more in depth study.

Anatomy of the Lymph System

Lymphatic System Functions

Lymphatic System and Immunity

Pathology of the Lymph Nodes and Lymphoma

Lymph Nodes

Lymph Fluid


Labels: , , , , , , ,

Saturday, October 17, 2009

Pancreatic cystic lymphangioma: report of a case.

Pancreatic cystic lymphangioma: report of a case.


Departments of Surgery, Istanbul University, CerrahpaSa School of Medicine, Istanbul. seryuce@istanbul.edu.tr

We herein present a patient referred to our clinic with the complaints of flatulence and left upper quadrant abdominal pain who was diagnosed to have pancreatic cystic neoplasia radiologically. The septated cyst was defined to be 9x12 cm in diameter by abdominal computed tomography and by ultrasonography originated from the tail of the pancreas. Distal pancreatectomy procedure with complete resection of the cystic lesion was performed in this patient. Pathologic examination revealed pancreatic cystic lymphangioma (PCL). Although PCL is very rare in adult patients, it can cause confusion due to the presence of other cystic pathologies of the pancreas. Complete excision of the cyst is mandatory to prevent recurrences. In our case, no recurrence was detected after a two-year follow-up.

Introduction

Lymphangiomas are rare congenital benign tumors arising from the lymphatic system (1), and are mostly encountered in the neck and axillary regions of pediatric patients (95%) (2). Lymphangioma cases have also been reported in other organs, such as the liver, spleen, lungs, mediastinum, colon, retroperitoneum, pancreas, omentum, pericardium, pleura, kidneys, ureters, bone, scrotum, penis, and cervix, etc. (2). Intraabdominal lymphangiomas are extremely rare, with a reported incidence of less than 1 in 20,000 to 1 in 250,000 hospital admissions (3). Pancreatic cystic lymphangioma (PCL) is mostly seen in female adults and particularly represents an exceptional report (3, 4). Since its first description by Koch in 1913, a literature review revealed only 64 PCL cases (4).

Lymphangiomas are classified into three groups as cystic, capillary and cavernous (2). Although rare, the diagnosis of PCL is not easy (3) and should be taken into account with other cystic neoplasms of the pancreas.

Case Presentation

A 50-year-old female patient was referred to our clinic with the complaints of flatulence and left upper quadrant abdominal pain. On physical examination, a palpable mass without clear borders was detected on the left subchondral region. All laboratory values, tumor markers and serologic tests were within normal limits.

Hemagglutination test for hydatid disease was negative. Abdominal computed tomography (CT) scan revealed a lobulated hypodense cystic mass 9x12 cm in diameter, originating from the tail of the pancreas (Figure 1). In ultrasonography (USG), the mass was defined to be a septated fluid-containing cyst. Upper gastrointestinal endoscopy revealed nothing but the erosive gastritis and there was no external compression to the stomach. Fine needle aspiration biopsy (FNAB) of the pancreas was performed, and lymphoid cell components in a benign cystic lesion were reported in the histologic examination.

The patient was operated with the preoperative diagnosis of pancreatic cystic neoplasia. Following the left subcostal incision, abdominal exploration was performed and a lobulated cystic lesion 10 cm in diameter originating from the tail of the pancreas and extending into the transverse mesocolon was detected. There was no invasion of the cyst into other organs or vascular structures. Distal pancreatectomy including the cyst and the distal onethird of the pancreas was performed. A clear liquid was aspirated from the cyst. The pancreas was closed with U-suture.

Macroscopic examination revealed a septated cystic lesion measuring 10x3x2 cm extending into the peripancreatic tissue; histopathology reported the cyst as peripancreatic lymphangioma with ectasia of the lymphatic vessels. Mature lymphocytes and rare macrophages were detected in the aspirated fluid (Figure 2). There was no postoperative complication.

Discussion

Lymphangiomas are endothelium-lined benign tumors that arise from the lymphatic system owing to congenital malformations. These malformations result in blockage of the lymphatic flow; thus, cystic dilatation of lymphatic channels occurs (5). Another theory is an inflammation leading to obstruction in lymphatic channels (3).

Lymphangioma is mostly encountered in the pediatric age group. They are characterized by cystic and cavernous spaces and are mostly localized in the neck and axilla (95%), whereas abdominal involvement is seen in about 1% of all cases (3,4). PCLs, described for the first time by Koch in 1913, are extremely rare lesions (4), and fewer than 100 cases have been reviewed in the literature (6).

Macroscopically, cystic lymphangiomas are multiloculated soft cystic masses that contain either serous or serohemorrhagic or lymphatic fluid. Dilated lymphatic channels of varying size divided by thin septae are observed histologically. The cystic wall is lined by thin and flat endothelial cells. Islands of lymphocytes can be present in the lumen and/or neighboring tissue (4). In our case, the cyst was found to be septated and contained clear fluid macroscopically, and the diagnosis of PCL was made on histopathologic examination.

Abdominal lymphangiomas (ALs) account for less than 1% of all lymphangiomas and can be seen in any age group but are more frequent in female adults (1, 3). In a study by Igarashi et al. (2) that included 45 pancreatic lymphangioma cases, the female:male ratio was found to be 29:16. ALs generally present with vague abdominal symptoms such as chronic abdominal pain, nausea and vomiting, distension, and palpable abdominal mass. These symptoms may develop acutely in children, whereas in adults, months or even years may pass from the onset of the symptoms until the diagnosis. Furthermore, although rare, acute abdomen can occur due to the complications such as intestinal obstruction, rupture and/or hemorrhage (7).

If the lymphangioma arises within the pancreatic tissue substance or if it is attached to the pancreas with a pedicle, it is termed as pancreatic lymphangioma (4). In our case, lymphangioma arose from the tail of the pancreas. In Igarashi’s review study (2), it was observed that PCLs mostly derived from the body and tail of the pancreas.

Abdominal US, CT, magnetic resonance imaging (MRI), angiography and FNAB can be employed for the preoperative diagnosis of lymphangiomas. In USG, septated cysts can be visualized. Although CT provides additional information about the characteristics of the lesion, the diagnosis is often not direct. The capsule and the septations of the cyst and their thickness and the characteristics of the fluid within can be evaluated with CT. Preoperative FNAB is still controversial as it might cause hemorrhage, rupture or tumor implantation in malignant cases (4). MRI does not yield any further information (1). None of the examinations described above are pathognomonic. A preoperative diagnosis of PCL is difficult. Definitive diagnosis can only be made by histopathologic examination of the resected lesion (7), and the diagnosis is supported immunohistochemically by positive staining of factor VIII-R antigen, CD31, and CD34 markers (2).

Although clinical follow-up with periodic imaging of patients with PCL has been suggested (8), surgery is the current treatment of choice (3, 4). Laparotomy is generally preferred; however, laparoscopic resection can also be performed in suitable cases. Total resection of the lesion is mandatory. In our case, we needed to perform distal pancreatectomy for the total removal of the lesion, and no recurrence has been observed after a two-year follow- up. We noted that in a review study by Igarashi (2) including 45 PCLs, six distal pancreatectomies were performed, and distal pancreatectomy procedure was also preferred in two cases by Casadei (4).

In summary, PCLs are very rare tumors and carry a potential risk of local invasion. Definitive diagnosis can only be made by histopathologic examination of the excised lesion. Total resection of the tumor is mandatory in case of recurrence. Therefore, as in our case, partial pancreatectomy may be needed in some patients.

Turkish Journal of Gastroenterology

Labels: , , , ,

Successful treatment of intraorbital lymphangioma with tissue fibrin glue.

Successful treatment of intraorbital lymphangioma with tissue fibrin glue.

Surg Neurol. 2009 Oct 12

Department of Neurosurgery, Kumamoto University Medical School, Kumamoto 860-8556, Japan.

BACKGROUND:

Although surgical resection is the first treatment choice in patients with cystic lymphangioma, the complete resection of orbital lymphangioma is often difficult. After partial resection of the cyst wall, some cystic lymphangiomas recur. The injection of tissue fibrin glue may prevent the recurrence of orbital lymphangioma.

CASE DESCRIPTION:

We present a 2-year-old girl with left progressive exophthalmos. Magnetic resonance imaging revealed a cystic mass lesion behind the left eyeball. At the first operation, the cyst wall was partially resected, and all cyst fluid was totally removed by suction. One week after the first operation, the cyst showed regrowth. At a second procedure, we injected tissue fibrin glue into the cyst. The cyst was completely sealed, and there was no recurrence.

CONCLUSION:

Tissue fibrin glue is adhesive and hemostatic and highly useful in the treatment of orbital cystic lymphangioma.

Elsevier



Labels: ,

Tuesday, September 29, 2009

The Unique biology of lymphatic edema

The Unique biology of lymphatic edema


Stanford Center for Lymphatic and Venous Disorders, Stanford University School of Medicine, Stanford, California 94305, USA. srockson@cvmed.stanford.edu

Sadly, the subject of lymphatic vascular insufficiency continues to engender relative neglect by health care professionals, which represents a source of frustration and fear among patients. A re-consideration of the unique, complex biology of lymphatic vascular disorders has the capacity both to reinvigorate interest and facilitate the implementation of the correct, existing treatment interventions for individuals affected by these disease states. While most of this complex lymphatic biology remains somewhat elusive, growing insights into the molecular mechanisms of lymphatic development and repair have been instructive. Present and future considerations in lymphedema diagnosis and management must acknowledge the unique tissue biology of this disorder. Many changes are unique to the lymphatic mechanisms of chronic edema. The profound stimulus to collagen deposition in the integument seems to be unique to chronic lymphatic edema, although this biology remains largely unexplicated. Several lines of evidence also suggest that lymphatic function has a unique and important influence upon adipose biology. Molecular investigation of murine models of human acquired lymphedema are beginning to shed light on these processes. Such focused mechanistic, approaches to the study of lymphedema and other lymphatic diseases are vital, as we attempt to expand our insights into the complex biology of lymphedema and its potential responsiveness to pharmacologic control and molecular intervention, prevention, and reversal.

MaryAnnLiebert

Labels: , ,

Contractile Physiology of Lymphatics

Contractile Physiology of Lymphatics


Department of Systems Biology and Translational Medicine, Cardiovascular Research Institute Division of Lymphatic Biology, Texas A&M Health Science Center College of Medicine, Temple, Texas 77843-1114, USA.

The lymphatic system has important roles in body fluid regulation, macromolecular homeostasis, lipid absorption, and immune function. To accomplish these roles, lymphatics must move fluid and its other contents (macromolecules, lipids/chylomicra, immune cells) from the interstitium through the lymphatics, across the nodes, and into the great veins. Thus, the principal task of the lymphatic vascular system is transport.

The body must impart energy to the lymph via pumping mechanisms to propel it along the lymphatic network and use pumps and valves to generate lymph flow and prevent its backflow. The lymphatic system utilizes both extrinsic pumps, which rely on the cyclical compression and expansion of lymphatics by surrounding tissue forces, and intrinsic pumps, which rely on the intrinsic rapid/phasic contractions of lymphatic muscle.

The intrinsic lymph pump function can be modulated by neural, humoral, and physical factors. Generally, increased lymph pressure/stretch of the muscular lymphatics activates the intrinsic lymph pump, while increased lymph flow/shear in the muscular lymphatics can either activate or inhibit the intrinsic lymph pump depending on the pattern and magnitude of the flow. To regulate lymph transport, lymphatic pumping and resistance must be controlled.

A better understanding of these mechanisms could provide the basis for the development of better diagnostic and treatment modalities for lymphatic dysfunction.

MaryAnnLiebert

Labels: , , , , , , , , ,

Vascular Malformations: an update

Vascular Malformations: an update


Division of Vascular and Endovascular Surgery and Vascular Malformation Clinic, Gonda Vascular Center, Mayo Clinic, Rochester, MN, USA. gloviczki.peter@mayo.edu , Division of Vascular and Interventional Radiology, Mayo Clinic, Rochester, MN, USA, Vascular Malformation Clinic, Gonda Vascular Center, mayo Clinic, Rochester, MN, USA, Division of Vascular and Endovascular Surgery, Gonda Vascular Center, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Vascular malformations occur as a result of an arrest in the development of the vascular system. The modified Hamburg classification distinguishes arterial, venous, arteriovenous, capillary, lymphatic, and mixed vascular malformations. Each malformation is further subdivided based on anatomy and on the time when arrest in development of the embryogenesis occurred; malformations can be truncular or extratruncular. Progress in the last decade in management has been significant because of improvements in open surgical procedures and perfection of percutaneous and hybrid endovascular interventions and devices, such as balloons, stents, and stent-grafts. There has been increasing use of embolization for the treatment of malformations with coils, other particles, glue, or with endovascular placement of occlusive plugs. Absolute alcohol, detergent liquids, or foam have been used for sclerotherapy with improved efficacy. The agents are delivered percutaneously or through a catheter placed either into the feeding arteries or the draining veins. This review aims to aid vascular and endovascular specialists in staying familiar with vascular malformations. These specialists need to be able to evaluate the patients, perform treatment if appropriate, or refer complex cases to multidisciplinary vascular malformation clinics and vascular centers.

Sage Publications


Labels: , ,

SoxF genes: Key players in the development of the cardio-vascular system.

SoxF genes: Key players in the development of the cardio-vascular system

Institute for Molecular Bioscience, The University of Queensland, Brisbane, Qld 4072, Australia.

SoxF genes (Sox7, Sox17 and Sox18) encode a group of transcription factors that have a pivotal role in cardio-vascular development. SOXF factors orchestrate endothelial cell fate or direct cell differentiation in developing heart, blood vessels and lymphatic vessels. Their roles are highly conserved throughout animal evolution. SOXF activity is finely tuned with a variety of cell type-specific co-factors and partner proteins to effect transcription of genes critical for endothelial cell phenotype and function. Because SOXF factors play a central role in cardiogenesis, vasculogenesis and lymphangiogenesis, SOXF gene mutations figure prominently in the aetiology of human vascular disease.

Wiley InterScience

Labels: , , , , , ,

Lymphatic Development

Lymphatic Development


Laboratory of Molecular Genetics, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.

email: Brant M. Weinstein (bw96w@nih.gov)

The lymphatic system is essential for fluid homeostasis, immune responses, and fat absorption, and is involved in many pathological processes, including tumor metastasis and lymphedema. Despite its importance, progress in understanding the origins and early development of this system has been hampered by lack of defining molecular markers and difficulties in observing lymphatic cells in vivo and performing genetic and experimental manipulation of the lymphatic system. Recent identification of new molecular markers, new genes with important functional roles in lymphatic development, and new experimental models for studying lymphangiogenesis has begun to yield important insights into the emergence and assembly of this important tissue. This review focuses on the mechanisms regulating development of the lymphatic vasculature during embryogenesis. Birth Defects Research (Part C)

Wiley InterScience

Labels: , , , , , , , ,

Sunday, September 20, 2009

Intrauterine Treatment of Large Fetal Neck Lymphangioma with OK-432.

Intrauterine Treatment of Large Fetal Neck Lymphangioma with OK-432.

Fetal Diagn Ther. 2009 Sep 11

Mikovic Z, Simic R, Egic A, Stosic Opincal T, Koprivsek K, Stanojevic D, Bogavac M, Popovac M, Mandic V.
Department of High-Risk Pregnancies, University Clinic of Gynaecology and Obstetrics 'Narodni Front', Belgrade, Serbia.


Lymphangiomas are benign vascular malformations of the lymphatic system and most commonly present in the neck area. Large lymphangiomas may compress and/or displace the larynx, trachea and esophagus and cause serious respiratory and feeding problems in neonates. Prenatal therapy could eliminate the risks of the mentioned complications. Prenatal therapy may include the EXIT (ex utero intrapartum treatment) procedure. As this procedure has certain risks for both the neonate and mother, the introduction of a safer method is justified. The use of OK-432, as a sclerosing agent, has shown positive results in several published cases of cystic hygroma, but there is no study about the prenatal use of this agent in the treatment of lymphangioma. The aim of this study was to present our experience with intrauterine intralesional injection of OK-432 in the treatment of neck lymphangiomas. Two cases of large multicystic neck lymphangiomas that were closely situated to the fetal airway were treated by single intralesional injection of OK-432. We noticed a progressive decrease in tumor volume throughout gestation. We did not experience any complications and there were no respiratory or feeding problems in the neonates. The esthetical appearance was satisfactory and both children were normal at the age of 2 years and 6 months, respectively. This report suggests that prenatal intralesional injection of OK-432 might be a safe and effective treatment in selected cases with large fetal neck lymphangiomas.


Fetal Diagnosis and Therapy

Labels: , , , , , , , ,

Thursday, September 17, 2009

Case report of fetal axillo-thoraco-abdominal cystic hygroma.

Case report of fetal axillo-thoraco-abdominal cystic hygroma.

Arch Gynecol Obstet. 2009 Apr 10

Masood SN, Masood MF.
Dow University of Health Sciences, Karachi, Pakistan,
sh_naz@yahoo.com.

Cystic hygroma (moist tumor) was first described in 1828 by Redenbacher. The cyst usually results owing to an absence or an inefficient connection between the lymphatic and venous systems. Of this type of malformation 75% cases are localized in the nuchal region; however, only 20% are found in the axilla while 5% of these hygromas are in other locations. Prognosis depends on associated fetal co-morbidities. There are many case reports on cystic hygroma but only a few on the axillo-thoraco-abdominal variant. This is a case report of a huge late-onset fetal axillo-thoraco-abdominal cystic hygroma, which was diagnosed at term followed by a difficult vaginal delivery in a 38-year-old woman. The baby did not have any congenital anomaly other than cystic hygroma with no evidence of intrathoracic or intra-abdominal extension of mass and a pelvic kidney reported on neonatal ultrasound and CT scan. The surgical excision of the cyst was done on the fourth day following birth and the histopathology report confirmed the diagnosis. Management of fetal cystic hygroma with the use of a sclerosing agent is a new modality being explored. Risk of recurrence in subsequent pregnancies for aneuploidy is not increased. The baby has been followed up to 5 months of birth and is thriving well. Karyotype shows an XX pattern.

SpringerLink

Labels: , , , , , , , ,

Monday, June 08, 2009

Abdominal lymphangioma in children: Report of three cases.

Abdominal lymphangioma in children: Report of three cases.
Surg Today. 2009
Muramori K, Zaizen Y, Noguchi S.
Department of Pediatric Surgery, Matsuyama Red Cross Hospital, Matsuyama, Japan.


Most cases of abdominal lymphangioma are asymptomatic. However, patients may occasionally present with acute abdomen because of an intestinal obstruction or peritonitis caused by infected cysts, hemorrhaging, and/or torsion. These conditions may differ based on the location of the lymphangioma and do not always require emergency surgery. This report presents two cases of abdominal lymphangioma derived from the omentum, which required emergency surgery because of severe abdominal distension and peritonitis caused by torsion, respectively. In contrast, another case of retroperitoneal lymphangioma presented with acute abdomen and underwent elective surgery after conservative therapy for peritonitis. Elective surgery is acceptable if the symptoms are controllable under conservative therapy. However, it is important not to overlook the possible lethal complications such as intestinal and/or urological obstruction, aggressive peritonitis, and torsion of the cyst, which require emergency surgery.

SpringerLink

Labels: , , , , ,

Cystic lymphangiomatous hamartoma masquerading as massive ascites.

Cystic lymphangiomatous hamartoma masquerading as massive ascites.
Indian J Pediatr. 2009 May

Parakh A, Dubey AP, Garg A, Khurana N, Aggarwal SK.
Department of Pediatric, Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India,
ankitparakh102@rediffmail.com.

We report a 4-year-old boy presenting with a tense massive ascites and large hydrocele. History and physical examination were unremarkable. Routine laboratory studies were normal. Abdominal ultrasonography revealed massive ascites. Contrast CT was suggestive of a large cyst covering the entire peritoneal cavity. At laparotomy, a large cystic tumor was found extending into the scrotum through the left inguinal ring. Histopathologic examination diagnosed the tumor as a cystic lymphangiomatous hemartoma. Although abdominal lymphangiomas are seen in children, but presenting as massive ascites with hydrocele is very rare.

SpringerLink

Labels: , , , , , ,

Congenital Lymphangioma Circumscriptum of the Vulva.

Congenital Lymphangioma Circumscriptum of the Vulva

Indian Pediatr. 2009 May

Aggarwal K, Gupta S, Jain VK, Marwah N.
Department of Dermatology, Venereology and Leprology and Department of Pathology, Post Graduate Institute of Medical Sciences and Research, Rohtak, India; and Department of Dermatology, Venereology and Leprology, MM Institute of Medical Sciences and Research, Mullana, Ambala, India. Correspondence to: Dr Sanjeev Gupta, HNo B2, Near Shiv Mandir, MM Medical College Residential Campus, Mullana, District Ambala, Haryana 133 203. India.
sanjeevguptadr@yahoo.com.

Lymphangioma circumscriptum of the vulva is a disorder of lymphatic channels involving deep dermal tissues. Most of these cases are confused with genital warts leading to improper diagnosis and treatment. We present a three years young female child who had multiple skin colored papular lesions over the genitals. Skin biopsy revealed features of lymphangioma circumscriptum.

IndianPediatrics.net (Full Text Article PDF)

Labels: , , ,

Tuesday, December 30, 2008

Molecular targets for therapeutic lymphangiogenesis in lymphatic dysfunction and disease.

Molecular targets for therapeutic lymphangiogenesis in lymphatic dysfunction and disease.
Lymphat Res Biol. 2008
Nakamura K, Rockson SG.

Stanford Center for Lymphatic and Venous Disorders, Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California.

Abstract

The convergence of multiple disciplines upon the study of the lymphatic vasculature has invigorated a renaissance of research, using powerful investigative tools and an exponential growth of interest in this historically underappreciated system. Fundamental discoveries in lymphatic development have yielded relevant animal models for vexing clinical diseases that suffer from nonexistent of minimally effective treatments. Inherited and acquired lymphedema represent the current crux of research efforts to identify potential molecular therapies born from these early discoveries. The importance of the lymphatic system is, however, not limited to lymphedema but encompasses a diverse spectrum of human disease including inflammation and cancer metastasis. As the lymphatic vasculature continues to benefit from fruits of biomedical investigation, translation of mechanistic insights into targeted, rationally-conceived therapeutics will be become a reality.

Mary Ann Liebert Publications

Labels:

The lymphatic system in health and disease.

The lymphatic system in health and disease.
Cueni LN, Detmar M.
Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, ETH Zurich, Zurich, Switzerland.


Abstract

The lymphatic vascular system has an important role in the regulation of tissue pressure, immune surveillance and the absorption of dietary fat in the intestine. There is growing evidence that the lymphatic system also contributes to a number of diseases, such as lymphedema, cancer metastasis and different inflammatory disorders. The discovery of various molecular markers allowing the distinction of blood and lymphatic vessels, together with the availability of a increasing number of in vitro and in vivo models to study various aspects of lymphatic biology, has enabled tremendous progress in research into the development and function of the lymphatic system. This review discusses recent advances in our understanding of the embryonic development of the lymphatic vasculature, the molecular mechanisms mediating lymphangiogenesis in the adult, the role of lymphangiogenesis in chronic inflammation and lymphatic cancer metastasis, and the emerging importance of the lymphatic vasculature as a therapeutic target.

Mary Ann Liebert Publcations

Labels: , ,